API report: outsourcing preferred, market to reach $119.7bn
The global active pharmaceuticals ingredients (APIs) market was $119.7 bn in 2014 and is predicted to reach $185.9 bn by 2020, according to a new report.
Archives for February 15, 2016
Zika research continues depite lack of animal models; Epidemiological studies underway
Zika researchers are using animal models and epidemiological studies to try and determine if the virus causes birth defects and neurological disorders.
First robotically driven experimentation system reduces drug discovery costs
Researchers have created the first robotically driven experimentation system which reduces the number of necessary experiments throughout drug discovery by 70%.
As Excipacted? Ashland plant certified GMP compliant under European industry-led scheme
An Ashland excipient facility in Kentucky has become the first US plant certified under Excipact, the European industry-led GMP quality scheme.
Collaboration seeks to develop genomic cancer assays
Silicon Biosystems Menarini and Macrogen announced they will form a partnership to provide clinical assays and new procedures for precision medicine in cancer.
China moves to prioritize and accelerate pediatric drug reviews
China has pledged to review drugs for serious childhood diseases ahead of other meds if developers can show they have significant therapeutic advantages over current treatments.
CTI Biopharma confirms a CRO is involved in Ph III trial halted after deaths
CTI Biopharma has confirmed the Phase III trial halted after patient deaths last week was being conducted by a CRO and in-house researchers.